Daniel L. Morganstein

Thyroid abnormalities following the use of cytotoxic T‐lymphocyte antigen‐4 and programmed death receptor protein‐1 inhibitors in the treatment of melanoma

Daniel L. Morganstein, Zhuangming Marc Lai, Lavinia Spain et al. · Clinical Endocrinology · 2016 · 188 citations

Medicine, Endocrinology, Oncology +17

A Functional Interaction between RIP140 and PGC-1α Regulates the Expression of the Lipid Droplet Protein CIDEA

Magnus Hallberg, Daniel L. Morganstein, Evangelos Kiskinis et al. · Molecular and Cellular Biology · 2008 · 157 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Acute management of the endocrine complications of checkpoint inhibitor therapy

Claire Higham, Anna Olsson‐Brown, Paul Carroll et al. · Endocrine Connections · 2018 · 131 citations · Full text

Pharmacy, Endocrinology, Oncology +17

Receptor Interacting Protein 140 Regulates Expression of Uncoupling Protein 1 in Adipocytes through Specific Peroxisome Proliferator Activated Receptor Isoforms and Estrogen-Related Receptor α

D Debevec, Mark Christian, Daniel L. Morganstein et al. · Molecular Endocrinology · 2007 · 93 citations · Full text

Life Sciences, Molecular Biology, Physiology +17

Human fetal mesenchymal stem cells differentiate into brown and white adipocytes: a role for ERRα in human UCP1 expression

Daniel L. Morganstein, Pensée Wu, Meritxell Rosell Mane et al. · Cell Research · 2010 · 81 citations · Full text

Life Sciences, Cell Biology, Physiology +16